Intelligence Platform
Patents
Browse 783 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.
US 7375079
Previns as specific inhibitors and therapeutic agents for botulinum toxin B and tetanus ne
granted patentUS 7374931
Vaccine against staphylococcus intoxication
granted patentUS 7371225
Method for convection enhanced delivery of therapeutic agents
granted patentUS 7355012
Mutated anti-CD22 antibodies with increased affinity to CD22-expressing leukemia cells
granted patentUS 7351435
Deglycosylated ricin toxin a-chain vaccine
granted patentUS 7348319
Nitric oxide-releasing amidine diazeniumdiolates, compositions and uses thereof and method
granted patentUS 7335356
Monoclonal antibodies and complementarity-determining regions binding to Ebola glycoprotei
granted patentUS 7332172
Transformed bacteria producing CS6 antigens as vaccines
granted patentUS 7320991
Analogs of thalidomide as potential angiogenesis inhibitors
granted patentUS 7317086
Basal cell carcinoma tumor suppressor protein
granted patentUS 7314632
Pseudomonas exotoxin A-like chimeric immunogens
granted patentUS 7312228
Cytotoxic indeno and isoindoloisoquinolones
granted patentUS 7306806
Recombinant P. falciparum merozoite protein-142 vaccine
granted patentUS 7300940
Integrin Ξ±-v Ξ²-3 antagonists for use in imaging and therapy
granted patentUS 7288254
Use of immunotoxins to induce immune tolerance to pancreatic islet transplantation
granted patentUS 7282205
Anti-hepatitis A virus antibodies
granted patentUS 7279294
Tumor markers in ovarian cancer
granted patentUS 7267941
Cyanovirin variant-polymer conjugates
granted patentUS 7267823
Ebola peptides and immunogenic compositions containing same
granted patentUS 7265215
DNA or RNA encoding a recombinant dengue envelope protein
granted patentUS 7264947
Activity dependent neurotrophic factor III (ADNF III)
granted patentUS 7261896
Methods for preventing strokes by inducing tolerance to e-selectin
granted patentUS 7261900
Recombinant modified Bacillus anthracis protective antigen for use in vaccines
granted patentUS 7259167
Antimalarial and antiproliferative pharmacophore models, novel tryptanthrin compounds havi
granted